최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기소아청소년정신의학 = Journal of the Korean Academy of Child and Adolescent Psychiatry, v.22 no.2, 2011년, pp.74 - 80
Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral disorder with an onset of symptoms before 7 years of age, often starting as early as the preschool years. The off-label use of methylphenidate (MPH) for 3- to 6-year-old preschool children with ADHD is being more common, although M...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
주의력결핍 과잉행동장애는 몇세 이전에 발병하는가? | 주의력결핍 과잉행동장애(attention-deficit hyperactivity disorder, ADHD)는 유전성이 높은 질환으로 7세 이전에 발병하는 것으로 알려져 있다.1) 7세에서 10세 사이에 가장 흔하게 진단되지만 ADHD 증상과 기능 손상은 학령전기, 즉 3세에서 5세 사이에서도 종종 나타난다. | |
학령전기 ADHD 아동은 무엇에 문제를 일으키는가? | 학령전기 ADHD 아동은 학습, 또래 관계, 가정 내의 문제를 일으키며3) 사고에 대한 위험성이 높고 쉽게 다치는 경향이 있다.4) 또한 학습 문제로 인하여 특수 교육 프로그램을 받게되는 경우가 종종 있고5) 공격적인 행동과 산만함으로 유치원을 다니는데 어려움을 겪는 경우도 있다. | |
주의력결핍 과잉행동장애는 언제 가장 흔히 진단되며 어느 나이대에 종종 나타나는가? | 주의력결핍 과잉행동장애(attention-deficit hyperactivity disorder, ADHD)는 유전성이 높은 질환으로 7세 이전에 발병하는 것으로 알려져 있다.1) 7세에서 10세 사이에 가장 흔하게 진단되지만 ADHD 증상과 기능 손상은 학령전기, 즉 3세에서 5세 사이에서도 종종 나타난다.2) 지역사회를 대상으로 한 역학 연구를 보면 학령전기 아동의 2~6%에서 ADHD 진단 기준을 만족하는 것으로 보고되어 있다. |
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text revision (DSM-IV-TR). Washington DC: American Psychiatric Press;2000.
Lavine JV, Gibbons RD, Christoffel KK, Arend R, Rosenbaum D, Binns H, et al. Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry 1996;35:204-214.
Dupaul GJ, McGoey KE, Eckert TL, Van Brakle J. Preschool children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2001;40:508-515.
Lahey BB, Pelham WE, Loney J, Kipp H, Ehrhardt A, Lee SS et al. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psy-chiatry 2004;161:2014-2020.
Lahey BB, Pelham WE, Stein MA, Loney J, Trapani C, Nugent K et al. validity of DSM-IV attention deficit hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry 1998;37: 695-702.
Pierce EW, Ewing LJ, Campbell SB. Diagnostic status and symptomatic behavior of hard-to-manage preschool children in middle childhood and early adolescence. J Clin Child Psychol 1998;28:44-57.
McGee R, Prior M, Williams S. The long-term significance of tea-cher-rated hyperactivity and reading ability in childhood: findings from two longitudinal stidies. J Child Psychol Psychiatry 2002;43: 1004-1017.
Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36(10 Suppl):85S-121S.
Offson M, Marcus SC, Weissman MM, Jensen PS. NAtional ternds in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 2002;41:514-521.
Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000;283:1025-1030.
Zuveska SH, Vitiello B, Norquist GS. Recent treds in stimulant me-dication use among U.S. children. Am J Psychiatry 2006;163:579-585.
US Food and Drug Administration. Medication guide: Ritalin. [accessed on 15 Feb 2011]. Available from http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089090.pdf.
Korean Food and Drug Administration. Medications that are prohibited in children and adolescents. [accessed on 15 Feb 2011]. Available from http://ezdrug.kfda.go.kr/kfda2.
Greenhill LL, Posner K, Vaughan BS, Kratochvil CJ. attention deficit hyperactivity disorder in preschool children. Child Adolesc Psychiatr Clin N Am 2008;17:347-366.
Schliefer M, Weiss G, Cohen N, Elman M, Cvejic H, Kruger E. Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry 1975;45:38-50.
Conners CK. Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. Int J Ment Health 1975;4:61-74.
Cunningham CE, Siegel LS, Offord DR. A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys. J Child Psychol Psychiatry 1985;26:955-971.
Barkley RA, Karlsson J, Strzelecki E, Murphy JV. Effects of age and Ritalin dosage on the mother-child interactions of hyperactive children. J Consult Clin Psychol 1984;52:750-758.
Barkley RA. The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc Psychiatry 1988;27:336-341.
Mayes SD, Crites DL, Bixler EO, Humphrey FJ 2nd, Mattison RE. Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status. Dev Med Child Neurol 1994;36:1099-1107.
Musten LM, Firestone P, Pisterman S, Bennett S, Mercer JJ. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. Am Acad Child Adolesc Psychiatry 1997; 36:1407-1415.
Handen BL, Feldman HM, Lurier A, Murray PJ. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry 1999;38:805-812.
Short EJ, Manos MJ, Findling RL, Schubel EA. A prospective study of stimulant response in preschool children: insights from ROC analyses. J Am Acad Child Adolesc Psychiatry 2004;43:251-259.
Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1998;8:13-25.
Greenhill LL, Kollins S, Abikoff H, McCracken JT, Riddle MA, Swanson J, et al. Efficacy and Safety of immediate-release methylphenidate for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45:1284-1293.
Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, et al. Safety and tolerability of methylpheniate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45: 1294-1313.
Vitiello B, Abikoff H, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, et al. Effectiveness of methylphenidate in the 10 month continuation phase of the preschoolers with attention deficit/hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmacol 2007;17:593-604.
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762-769.
Wigal SB, Gupta S, Greenhill L, Posner K, Lerner M, Steinhoff K, et al. Pharmacokinetics of methylphenidate in preschoolers with attention- deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:153-164.
Maayan L, Paykina N, Fried J, Strauss T, Gugga SS, Greenhill L. The open-label treatment of attention-deficit/hyperactivity disorder in 4- and 5-year-old children with beaded methylphenidate. J Child Adolesc Psychopharmacol 2009;19:147-153.
Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML, March JS, Kol-lins SH, Murray DW, et al. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:175-185.
Ghuman JK, Aman MG, Ghuman HS, Reichenbacher T, Gelenberg A, Wright R, et al. Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2009; 19:155-166.
Cesena M, Lee DO, Cebollero AM, Steingard RJ. Case study: behavioral symptoms of pediatric HIV-1 encephalopathy successfully treated with clonidine. J Am Acad Child Adolesc Psychiatry 1995; 34:302-306.
Lee BJ. Clinical experience with guanfacine in 2-and 3-year-old children with attention-deficit hyperactivity disorder. Infant Mental Health 1997;18:300-305.
Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999;38:1551-1559.
Scahill L, Barloon L, Farkas L. Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Nurs 1999;12:168-173.
Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. The Texas Children's Medication Algorithm Project : revision of the algorithm for pharmacotherapy of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45:642-657.
Campbell NB, Tamburrino MB, Evans CL, Franco KN. Fluoxetine for ADHD in a young child. J Am Acad Child Adolesc Psychiatry 1995;34:1259-1260.
Riddle MA, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry 2001;42:73-90.
Connor DF. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treat-ment. J Dev Behav Pediatr 2002;23(1 Suppl):S1-S9.
Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lie-berman AF, et al. Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry 2007;46:1532-1572.
Vaughan BS, March JS, Kratochvil CJ. The evidence-based pharmacological treatment of paediatric ADHD. Int J Neuropsychopharmacol; 2011. p.1-13.
Ghuman JK, Arnold LE, Anthony BJ. Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psy-chopharmacol 2008;18:413-447.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.